素饮食通过氨酸β-氧基化重新塑造癌症代谢
Junhong Qin1, Xinhe Huang2, Shengsong Gou1
1Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Paediatrics, West China Second University Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Nature metabolism
|August 12, 2024
概括
性饮食会诱导氨酸β-氧基化 (Kbhb),这种改变会影响癌细胞代谢. 这项研究确定了关键的Kbhb位点,比如在阿尔多酶B上,并开发了一种工具来预测功能修饰位点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- Lysine β-hydroxybutyrylation (Kbhb) 是一种由性饮食 (KD) 诱导的翻译后修饰.
- KD对各种人类疾病具有治疗潜力.
- 在细胞过程中Kbhb的调节作用仍然在很大程度上未被探索.
研究的目的:
- 研究KD对蛋白Kbhb的影响.
- 开发一种生物信息学方法,用于预测功能上重要的氨酸修饰位.
- 阐明Kbhb在癌细胞代谢中的作用.
主要方法:
- 对老鼠肝脏进行多组分析,以评估Kbhb蛋白水平.
- 开发和应用pFunK算法,用于预测功能性氨酸修饰部位.
- 在体外研究中使用肝细胞癌细胞与KD或β-基酸补充剂.
主要成果:
- 蛋白Kbhb被KD显著改变,这是多omics分析表明的.
- 该pFunK算法确定了功能相关的Kbhb位点,包括在Lys108.8.的阿尔多酶B (ALDOB) 上.
- 对ALDOB的Kbhb修改抑制了它的酶活性,抑制了癌细胞的增殖,并影响了mTOR信号和糖解.
结论:
- Kbhb在调节癌细胞代谢方面发挥着至关重要的作用.
- pFunK算法是预测功能重要氨酸修饰位点的宝贵工具.
- 准Kbhb可能为癌症治疗提供新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


